BOSTON — The founder of a pharmaceutical company charged with leading a nationwide conspiracy to bribe doctors to prescribe an opioid pain medication has won his bid to remove his electronic monitoring bracelet.
U.S. Magistrate Judge Jennifer Boal in Boston said Nov. 27 that prosecutors have shown no evidence that John Kapoor, 74, of Arizona-based Insys Therapeutics Inc. intends to flee. Prosecutors said at a hearing this month the Indian American entrepreneur should remain on GPS monitoring because he's a flight risk.
Kapoor and other Insys executives are accused of offering kickbacks to doctors to write large numbers of prescriptions for a fentanyl-based pain medication that's meant for cancer patients.
Defense attorney Brian Kelly said Kapoor is grateful for the ruling and looks forward to fighting the charges.
According to an earlier story in India-West, Kapoor said will fight the charges against him and believes he will be vindicated, his attorney said Nov. 16.
Kapoor pleaded not guilty in Boston's federal courthouse; his lawyer said he isn't a flight risk and wants to clear his name in court.
“He's not going to desert the USA because of this case,” Kelly told the judge. “He doesn't believe it's a strong case. He wants to fight this case.”
Insys Therapeutics, whose corporate offices are in Chandler, Ariz., is a specialty pharmaceutical company. It focuses on providing therapeutic solutions to help improve patients' lives, according to its website.
Former CEO Michael L. Babich and others are set to go to trial next year and have pleaded not guilty.
Kapoor has been free on $1 million bail since he was arrested by a dozen armed agents in his home state of Arizona last month, according to his attorney. He emigrated from India decades ago, is now a U.S. citizen and handed over his passport to authorities after his arrest.
Assistant U.S. Attorney Nathaniel Yeager said prosecutors fear he will flee the country, adding that they believe he has access to at least $2 billion.